Postdoctoral researchers sought for a precision medicine program addressing TP53-mutated myeloid neoplasms. Develop targeted therapies using in vitro/in vivo assays and xenograft models. PhD required, 1–5 years postdoc experience, strong publications. Competitive compensation and benefits.